desipramine has been researched along with Injuries, Spinal Cord in 2 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, JE | 1 |
Liu, BP | 1 |
Park, JH | 1 |
Strittmatter, SM | 1 |
Rawlow, A | 1 |
King, RG | 1 |
2 other studies available for desipramine and Injuries, Spinal Cord
Article | Year |
---|---|
Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
Topics: 5,7-Dihydroxytryptamine; Animals; Axons; Behavior, Animal; Blotting, Northern; Blotting, Southern; B | 2004 |
The effects of desipramine (DMI) and alpha-2 adrenoceptor agonists on flexor reflex activity (FRA) in the spinalized and decerebrate rat.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cordotomy; Decerebrate State; Desi | 1991 |